0000899243-21-002729.txt : 20210121
0000899243-21-002729.hdr.sgml : 20210121
20210121180435
ACCESSION NUMBER: 0000899243-21-002729
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210111
FILED AS OF DATE: 20210121
DATE AS OF CHANGE: 20210121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wittouck Amaury
CENTRAL INDEX KEY: 0001841311
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 21543124
MAIL ADDRESS:
STREET 1: VALLEY PARK
STREET 2: 44, RUE DE LA VALLEE
CITY: LUXEMBOURG
STATE: N4
ZIP: L2661
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-01-11
0
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001841311
Wittouck Amaury
VALLEY PARK, 44, RUE DE LA VALLEE
LUXEMBOURG
N4
L-2661
LUXEMBOURG
1
0
1
0
Common Stock
32259461
I
See Footnotes
Common Stock
3516214
I
See Footnotes
Common Stock
35402689
I
See Footnotes
On January 11, 2021, the Reporting Person became the sole member of the board of Stichting Administratiekantoor Westend (the "Stichting"), and therefore, may be deemed to beneficially own the securities reported herein. The Reporting Person disclaims beneficial ownership over the securities reported herein, except to the extent of his pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, the Reporting Person states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
These securities are directly held by Artal International S.C.A.
These securities are directly held by Invus Public Equities, L.P.
These securities are directly held by Invus, L.P.
The Reporting Person is the sole member of the board of the Stichting. The Stichting is the majority stockholder of Westend S.A. Westend S.A. is the parent company of Artal Group S.A. Artal Group S.A. is the sole stockholder of Artal International Management S.A., which is the managing partner of Artal International S.C.A. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. and through its Geneva branch is the sole stockholder of Artal Treasury Limited. Artal Treasury Limited is the managing member of Invus Public Equities Advisors, LLC. Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P.
Invus Partners, LLC directly holds 4,321,214 shares of Issuer common stock. Neither the Reporting Person nor any of the other entities listed in Footnote 5 hereof have any beneficial or pecuniary interest for purposes of Section 16 of the Exchange Act in the shares of Issuer common stock directly held by Invus Partners, LLC. For purposes of Section 16 of the Exchange Act, the Reporting Person and the other entities listed in Footnote 5 may be deemed to be directors by deputization of the Issuer by virtue of Invus, L.P.'s right to designate certain members of the Issuer's board of directors pursuant to a stockholders' agreement between the Issuer and Invus, L.P.
/s/ Amaury Wittouk
2021-01-21